Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S
The mean difference between the subgroups was 2.9 mmol mol 1 (95% CI, 5.7 to 0.1 mmol mol 1
Patients seeking GLP-1 therapy should consult healthcare providers about FDA-approved options
Packaging was discreet, product was exactly as described

CrossRef Senescent fibroblasts drive CD8+ T cell dysfunction in colorectal cancer via CD36-mediated lipid transfer and peroxidation Mengxiao Ge, Shuangyi Sun, Wentong Chen, Zhenxiao Xu, Deyi Kang, Zeqin Wang, Yumeng Guo Journal of Translational Medicine .2026;[Epub] CrossRef Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial Hyunjae Shin, Youngsu Park, Byeong Geun Song, Won-Mook Choi, Hyung Joon Han, Youngwoo Lee, Tae-Jin Song, Jong-Eun Yeon, Young-Suk Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Joon Hyeok Lee, Jung-Hwan Yoon, Jeong-Hoon Lee Cancer Immunology, Immunotherapy .2026;[Epub] CrossRef Dietary lipids synergistically enhance PAH bioavailability and intestinal toxicity: Mechanistic insights from a Caco-2 model Xiaofang Liu, Jie Zhu, Wanyi Zou, Li Liang, Jixian Zhang, Chaoting Wen, Youdong Li, Guoyan Liu, Xin Xu Food Bioscience .2026

Strategic Solutions for Informed Decision-Making Gain insights to stay ahead and seize opportunities